Matrix metalloproteinase-14 (MMP-14) plays important roles in cancer metastasis, and the failures of broad-spectrum MMP compound inhibitors in clinical trials suggested selectivity is critical. By grafting an MMP-14 specific inhibition motif into complementarity determining region (CDR)-H3 of antibody scaffolds and optimizing other CDRs and the sequences that flank CDR-H3, we isolated a Fab 1F8 showing a binding affinity of 8.3 nM with >1000-fold enhancement on inhibition potency compared to the peptide inhibitor. Yeast surface display and fluorescence-activated cell sorting results indicated that 1F8 was highly selective to MMP-14 and competed with TIMP-2 on binding to the catalytic domain of MMP-14. Converting a low-affinity peptide inhibitor into a high potency antibody, the described methods can be used to develop other inhibitory antibodies of therapeutic significance.
Matrix metalloproteinases (MMPs) are a group of structurally related zinc-dependent endopeptidases capable of cleaving almost all extracellular and basement membrane proteins (Visse and Nagase, 2003) . Among them, the membrane Type I matrix metalloproteinase (MT1-MMP, or MMP-14) has been recognized as one of the most crucial MMPs in cancer development and metastasis (Genís et al., 2006; Morrison et al., 2009) . Several broad-spectrum MMP inhibitors have been developed in the last 20 years for evaluation as cancer treatments. However, all these small compound MMP inhibitors failed in clinical trials due to low efficacy and adverse side effects caused by their poor selectivity among the MMP family members (Turk, 2006; Zucker and Cao, 2009) .
Recently, a cyclic peptide GACFSIAHECGA (Peptide G) able to selectively inhibit MMP-14 without cross-reactions to other MMPs has been reported (Suojanen et al., 2009) . This peptide inhibitor effectively prevented cancer cell migration and invasion in vitro, and dramatically reduced the growth of tongue carcinoma in xenografts with prolonged survival periods. Unfortunately, Peptide G exhibited a considerably low affinity of 150 µM with a relatively short half-life, diminishing its therapeutic potential as a potent inhibitor for cancer treatments.
Emerging as promising therapeutic agents, monoclonal antibodies had notable successes in targeting cancer cell surface antigens. mAbs usually have high affinity and high specificity, given the large antigen-antibody contact surface provided by multiple complementarity determining regions (CDRs). Encouraged by numerous studies of CDR transplantation (Moroncini et al., 2004; Frederickson et al., 2006; Qin et al., 2007; Kogelberg et al., 2008; Zhang et al., 2015) , we hypothesize that grafting an inhibitory motif into a CDR, especially CDR-H3, will confer binding specificity and thus the inhibition function on the antibody. In this study, we designed and synthesized human antibody Fab libraries in which Peptide G was incorporated into CDR-H3 (Fig. 1A) .
The Peptide G sequences with or without terminal cysteines (CFSIAHEC or FSIAHE) were utilized as the inhibition warhead, which was flanked by two random amino acid residuals (encoded by NNS) at both ends for selection of variants able to properly present the motif within the antibody scaffold (Table S1 , Supplementary data are available at PEDS online). The CDR-H3 fragments encoding Peptide G were assembled from synthetic oligonucleotides and cloned into an existing Fab library , which was built on a single framework of germline VH segment DP47 and Vκ segment DPK22 due to their high prevalence in human and decent expression levels in Escherichia coli (Knappik et al., 2000; Ewert et al., 2003) . In addition to CDR-H3, the Fab library had randomizations on other five CDRs as previously described , with total theoretical diversities of 6.9 × 10 8 for V L and 1.6 × 10 5 for V H .
Electroporation of 200 optical density highly competent E. coli XL1-blue cells with 3 µg DNA ligation samples generated 5 × 10 8 transformants. Ninety-five colonies from the constructed library were randomly picked for V L and V H sequencing. Results indicated that 93% of sequenced V L genes and 87% of sequenced V H genes were functional with the inhibition motifs correctly incorporated at CDR-H3s. Among sequenced V H genes, 3% had a stop codon at their NNS positions, and the remaining 10% had either readingframe shifts or non-designed mutations, likely introduced by primer mismatches during polymerase chain reaction (PCR). Analysis of the amino acid usages at the four NNS positions flanking CDR-H3s, showed distributions of all 20 amino acids as designed. Interestingly, proline and glycine were highly represented at these NNS positions compared with designs. Particularly, proline accounted for 27% and 24% at H95 and H96; and glycine accounted for 38% and 28% at H100E and H100F. Probably, proline and glycine codons have high GC contents; therefore, their fragments were assembled more efficiently than other amino acids during PCR.
The constructed library was subjected to four rounds of phage panning against immobilized MMP-14 catalytic domain (cdMMP-14), which was refolded from denatured inclusion bodies produced in E. coli. Monoclonal Fab phage ELISA of 288 randomly picked colonies from the third and the fourth rounds of panning identified 19 unique clones with significantly high signals over bovine serum albumin background. Sequencing results of these clones indicated that all these isolated 19 Fabs carried a correct Peptide G motif. Among them, 7 clones had the two cysteines flanking the inhibition warhead, while the remaining 12 clones did not have these cysteines. Genes of these 19 isolated Fabs were sub-cloned for expression in E. coli periplasm under the control of a PhoA promoter and a STII leader peptide. Except clones 1B5 and 1D11, which produced 200 µg purified Fabs per litter of culture, the majority of identified clones yielded 10 μg/L or less.
Binding affinity characterizations by ELISA with purified Fabs indicated that most Fabs showed a weak binding to cdMMP-14 with affinities at µM range. However, Fab 1F8 (its six CDR sequences shown in Fig. 1B) , exhibited a high affinity of 8.3 nM (EC 50 value) to cdMMP-14 (Fig. 1C) . At the same conditions, Fab DX-2400 (a high potent MMP-14 inhibitory antibody; Devy et al., 2009) showed EC 50 of 4.5 nM, suggesting the affinities of Fabs 1F8 and DX-2400 were in the same order of magnitude. More importantly, the inhibitory functions of purified Fabs against cdMMP-14 were then tested using an förster resonance energy transfer (FRET) peptide substrate. Among isolated MMP-14 binding Fabs, 1F8 showed a significant inhibition with K I of 110 nM (Fig. 1D) . Compared with the potency of Peptide G at 150 µM, Fab 1F8 exhibited an improvement of potency by three orders of magnitude. It demonstrates that grafting an inhibition (Devy et al., 2009) . (D) Inhibition function of purified Fabs 1F8 and DX-2400. An 1 μM quenched-fluorescent substrate peptide and 1 nM cdMMP-14 were used in förster resonance energy transfer (FRET) inhibition assays. K I values were calculated based on the models described in Cer et al. (2009). warhead to antibody scaffolds is a practical strategy able to convert a low potency peptide inhibitor into a high potent inhibitory antibody.
To test whether the grafted motif is crucial for MMP-14 binding and inhibition, two 1F8 mutants at its CDR-H3 were constructed. It has been suggested that a randomly scrambled sequence (CGAAPEACGIHS) and the cysteine to serine mutation (SFSIAHES) of Peptide G dramatically lost their binding and inhibition abilities (Suojanen et al., 2009) . Therefore, 1F8 CDR-H3 was replaced with these two designs, and mutated Fabs were produced in E. coli for characterizations by ELISA and FRET inhibition assays. Results showed that both constructed 1F8 mutants exhibited background ELISA signals to cdMMP-14 ( Fig. 2A ) without significant inhibition activities (Fig. 2B) . These results clearly indicated that Peptide G motif was required for the binding and inhibition capabilities of 1F8, and the cysteine residues flanking the motif were also crucial, likely due to the formation of a disulfide bridge to stabilize the inhibitory loop.
To further characterize 1F8, i.e. selectivity among MMPs and epitope determination, milligrams of purified Fab 1F8 are required. However, these efforts were hampered by limited expression level of Fab 1F8 in E. coli. Expressions under a strong pLac promoter, and with facilitation of periplasmic molecular chaperones DsbA/C coexpression were attempted, but results showed marginal improvement of yields. Given the advanced protein synthesis machineries of eukaryotic systems, 1F8 was cloned for display on yeast cell surface and characterizations by flow cytometry. To achieve effective display, scFvs of 1F8 and control clones were constructed with N-terminal Aga2 fusion and C-terminal c-Myc tag (Boder and Wittrup, 1997; Kondo and Ueda, 2004; Chao et al., 2006) . The expression of scFvs on yeast surface was confirmed by labeling with primary chicken anti-c-Myc IgY and secondary Alexa647-goat anti-chicken IgG. For selectivity tests, cdMMP-14 and cdMMP-9 were chemically crosslinked with Alexa488 and Alexa647, respectively, and the activities of resulted conjugates were verified using their FRET peptide substrates. After incubation with 200 nM dye conjugated cdMMP-14/-9, yeast cells displaying scFvs were analyzed by fluorescence-activated cell sorting (FACS). Results showed that when labeled with Alexa488-cdMMP-14, cells displaying 1F8 showed 4-fold higher signals than host cell line (EBY100) without scFv expression (Fig. 3A) , while the signals on Alexa647-cdMMP-9 were approximately same for 1F8 cells and EBY100 (Fig. 3B) , suggesting high selectivity of 1F8 toward MMP-14 over MMP-9.
We next profiled the epitope of 1F8, by dual color FACS using the N-terminal domain of tissue inhibitor of metalloproteinase-2 (n-TMIP-2), a native inhibitor of MMP-14 competitively targeting at the reaction cleft of MMP-14 with a K I of 1.2 nM (FernandezCatalan et al., 1998; Butler et al., 1999) . n-TIMP-2 was produced without refolding via soluble expression in the periplasma of E. coli , and fluorescently conjugated with Alexa647. MMP-14 inhibitory scFv DX-2400 (Devy et al., 2009; Ager et al., 2015) was displayed on yeast surface as a positive control. Irrelevant scFv M18 (anti-PA; Hayhurst et al., 2003) and MMP-14 specific but non-inhibiting scFv 2A10 (isolated in this study) were also cloned to serve as negative controls. The yeast cells displaying these antibody fragments were incubated with Alexa488-conjugated cdMMP-14 and Alexa647-conjugated n-TIMP-2 sequentially (Fig. 4A) . Three scenarios are expected: (Scenario 1) observation of non-specific antibody clones (Fig. 4A left) that do not bind to target antigen (cdMMP-14) or native inhibitor (n-TIMP-2), therefore producing low signals on both fluorophores (region Q4 on the scatterplot); (Scenario 2) observation of specific but non-inhibitory antibodies (Fig. 4A middle) that bind to cdMMP-14 at epitopes far from the catalytic pocket, hence not interfering with binding of n-TIMP-2 and generating high signals on both fluorophores (Q2) and (Scenario 3) observation of inhibitory antibodies (Fig. 4A right) that bind to desired epitopes and block n-TIMP-2, resulting in a high signal on cdMMP-14 but a low signal on n-TIMP-2 (Q1).
As experimental results shown in Fig. 4B , yeast cells displaying scFv M18 had 96% of its population located in Q4, therefore it is a non-specific antibody to MMP-14 as expected (Scenario 1). Dual color FACS scanning of yeast cells displaying scFv 2A10 showed 73% of its population located in Q2 (high signals in both Alexa488 and Alexa647 channels), confirming that 2A10 was a specific but non-inhibitory antibody (Scenario 2). The FACS results of 1F8, which exhibits a high affinity in ELISA (Fig. 1C) and inhibitory function in FRET assays (Fig. 1D) , showed that 78% of its population located in region Q1 (Scenario 3) with only 19% in region Q2, indicting 1F8 was significantly different from the specific but noninhibitory clones such as 2A10. A known MMP-14 inhibitory antibody DX-2400 exhibited similar scatterplot as that of 1F8, e.g. 67% in Q1 and 32% in Q2. Notable, DX-2400 showed a higher mean of Alex488-cdMMP-14 signals than that of 1F8, presumably due to its decent expression level and high potency (Devy et al., 2009; Ager et al., 2015) . Collectively these FACS scanning results suggested that 1F8 was an inhibitory antibody, and it competed with n-TIMP-2 on binding to cdMMP-14, likely either directly interacting with the vicinity of cdMMP-14 reaction cleft, or allosterically acting as an exosite inhibitor (as examples demonstrated in Wu et al., 2007; Farady et al., 2008) .
In our previous study, high concentrations of n-TIMP-2 were used as an eluent to release the antigen-binding phages from the cdMMP-14 bait, resulted in the discovery of 14 inhibitory antibodies ). In the current study, we investigated the binding profiles of isolated antibodies by applying the similar competition between n-TIMP-2 and antibodies, not in ELISA plates but on yeast cell surface. We found that when antibodies like 1F8 and DX-2400 occupy the active site, n-TIMP-2 at low concentrations loses its ability to bind cdMMP-14; when high concentrations (i.e. 2 µM) of n-TIMP-2 were applied, cdMMP-14 will be released from the surface of 1F8/DX-2400 displaying cells. These results consistently suggested that 1F8 and DX-2400 directly competed with n-TIMP-2. In addition, this epitope-specific dual color FACS has potentials to be applied as a novel function-based high-throughput screening method to directly mine synthetic or naïve antibody libraries for inhibitory antibodies.
To further elucidate the inhibition model of 1F8, computational simulations were performed to predict Fab 1F8/cdMMP-14 complex structure. Using the multiple functions provided at Structural Antibody Prediction Server (SAbPred; , Fab 1F8 structure was generated, and applied for paratope prediction and epitope mapping with the aid of reported structure of cdMMP-14 (PDB ID 1bqq; Fernandez-Catalan et al., 1998). Fab 1F8 and cdMMP-14 were then docked using ZDOCK with the generated paratope/epitope prediction results as restraints. As shown in Fig. 5 , structure simulation indicates that the grafted Peptide G motif (yellow in Fig. 5 ) penetrates into the reaction cleft of cdMMP-14, suggesting the inhibition function of Fab 1F8 is likely given by direct interaction with MMP-14 active site. In addition, Pro259 and Phe260 of MMP-14 (green in Fig. 5 ), as the key residues forming MMP-specific S1′ substrate binding site (Nagase, 2001; Gupta and Patil, 2012) , were identified as the possible epitopes, and thus may partially explain the high selectivity of 1F8.
In summary, with the hypothesis that grafting an inhibitory peptide into CDR-H3 confers binding specificity and inhibition effect to the antibody, in this study, a synthetic antibody library was generated to optimize the sequences flanking CDR-H3 and other five CDRs of both the heavy and light variable domains. After phage panning, among dozens of affinity binders, one inhibitory antibody, Fab 1F8, with binding affinity (EC 50 ) of 8.3 nM and inhibition potency (K I ) of 110 nM was isolated, demonstrating the successful conversion of a low-affinity peptide inhibitor to an inhibitory antibody with high selectivity and >1000-fold enhancement of potency. Tests with 1F8 mutants confirmed that the grafted Peptide G motif played an important role for MMP-14 inhibition. Yeast cell surface display and followed FACS analysis indicated 1F8 direct competed with n-TIMP-2 on binding with MMP-14. And computational simulation suggested the interaction is likely through direct binding to the vicinity of MMP-14 reaction cleft.
The MMP family members are promising drug targets in many states of pathologies (Cook et al., 2000; Elkington et al., 2005; Overall and Kleifeld, 2006; Dev et al., 2010; Castro and Tanus-Santos, 2013) . Besides MMP-14, peptide inhibitors toward other MMP family members have also been identified (Koivunen et al, 1999; Heikkilä et al., 2006) . It is highly likely that the methodology of this study could be readily applied for the generation of highly selective inhibitory antibodies targeting additional individual MMPs. In addition to therapeutic potentials, these inhibitors with high selectivity can also be exploited as research tools to shed more light on the MMP functionality in normal and patho-physiological conditions. Other than MMP family members, we also expect that the techniques described here, i.e. motif grafting (Moroncini et al., 2004; Frederickson et al., 2006; Qin et al., 2007; Kogelberg et al., 2008; Zhang et al., 2015) , CDR optimization and epitope-specific FACS, are valuable on development of high potency inhibitory antibodies based on peptide inhibitors.
Supplementary data
Supplementary data are available at Protein Engineering, Design & Selection online. tom of the reaction pocket. Fv 1F8 (cartoon, cyan) binds to vicinity of cdMMP-14 reaction cleft through direct interaction between the grafted Peptide G motif (yellow) and the active site. MMP-14 residues Pro259 and Phe260 (sticks, green) form the S1′ MMP-specific substrate binding pocket. Model of Fab 1F8 was generated using SAbPred . Fab 1F8 and cdMMP-14 were docked using ZDOCK . Images were generated using PyMOL.
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Construction of Motif Grafting Library. DNA fragments encoding the inhibition motif of Peptide G (CFSIAHEC or FSIAHE) were assembled with two flanking randomized residues (encoded by NNS) by overlap extension PCR using synthesized degenerate primers (Table S1) . Amplified motif fragments were digested with BglII/NdeI and inserted to the Fab phagemids of a synthetic library having 5×10 9 variants . After digestion and ligation, 3 µg of ligated DNA was transformed with 200 OD of highly competent cells of XL1-blue for library generation.
Phage Display and ELISA Screening. Standard protocols were applied for phage preparations and ELISAs (Pardon et al., 2014; Fellouse and Sidhu, 2007) . Briefly, Maxisorp 96-well immunoplates (Thermo Nunc) were coated with 4 µg/ml cdMMP-14 and blocked with 5% BSA. Phage particles with 100-fold excess to the library diversity were prepared and depleted on BSA coated wells for 1 hr at RT with gentle shaking. BSA depleted phage library was incubated in cdMMP-14 coated wells for 1 hr at RT. Then the wells were washed 10 times with TBS buffer containing 0.1% Tween 20 (TBST) and 5 times with TBS buffer. cdMMP-14 binders were eluted by incubation with 100 mM HCl and followed by neutralization with 1 M Tris-HCl (pH 8.0). Eluted phages were amplified by infecting XL1-Blue cells, and underwent three additional rounds of panning. From the second round, the washing stringency was increased to 20 times with TBST and 5 times with TBS. In the third round, the antigen concentration was reduced into half. Phages enriched from the third and fourth rounds were screened by monoclonal Fab phage ELISA to identify cdMMP-14 binders. 96-well plates were coated with cdMMP-14 and blocked with BSA or coated with BSA only. The coated plates were incubated with rescued phage cultures, and signals were developed by using anti-M13-HRP conjugate and TMB substrate. The ratios between the signal associated cdMMP-14 and that of BSA were calculated to identify positive binding clones.
Fab Cloning, Expression and Purification. The Fab genes of isolated phages were cloned into a vector containing a PhoA promoter, a STII leader peptide and a C-terminal His tag (Fellouse and Sidhu, 2007) . Constructed Fab expression plasmids were transformed into E. coli Jude-I for cultivation in 2×YT media at 30 o C. The cells were harvested and treated with osmotic shocks to recover periplasmic fractions (Goldman et al., 2002; Nam and Ge, 2013) . Fab proteins were purified by affinity chromatography using Ni-NTA resin, and dialyzed against 50 mM HEPES (pH 6.8), 150 mM NaCl to remove residual imidazole (a weak inhibitor of MMPs). The homogeneity of purified antibody fragments was verified by SDS-PAGE, and Fab concentrations were measured with NanoDrop 2000 (Thermo Scientific). To construct Fab expression vector under a Lac promoter, the VH and VL fragments were PCR amplified and cloned into NcoI/NotI and NheI/HindIII sites on pMAZ360-IgG (Mazor et al., 2007) , respectively. A 10×His tag with a stop codon was introduced after the CH1 domain. Constructed plasmids were transformed into E. coli Jude-I for expression in TB media by induction with 0.2 mM IPTG at 30 o C overnight. To improve expression level of Fab 1F8, pBAD33-DsbA, pBAD33-DsbC, pBAD33-DsbAC-1P (under one promoter), and pBAD33-DsbAC-2P (under two separate promoters) were transformed into Jude-I harboring the 1F8 Fab plasmid. Co-expression of 1F8 Fab and molecular chaperones was induced by 0.2% arabinose in 2×YT supplemented with 100 µg/ml ampicillin and 35 µg/ml chloramphenicol at 30 o C overnight.
Affinity and Inhibition Assays. In Fab ELISA, 96-well plates were coated with cdMMP-14 (4 µg/ml) overnight at 4 o C, and washed 2 times with TBST. The plates were blocked with 0.5% BSA for 2 hr at RT followed by washing 2 times with TBST. Purified Fabs were serially diluted into cdMMP-14 coated wells and incubated at RT for 1 hr followed by 3 washes with TBST. The coated plates were incubated with anti-M13-HRP conjugate and TMB solution was added to develop the signals. The signals at OD 450 were measured using a Synergy H4 microplate reader (BioTek). The half-maximal effective concentration (EC 50 ) was calculated from a fourparametric logistic curve-fitting analysis. For Fab inhibition assays, the enzymatic activities of 1 nM cdMMP-14 in the presence of various concentrations Fabs were measured at 37 o C by monitoring the hydrolysis of 1 µM fluorogenic peptide Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 at λ ex = 328 nm and λ em = 393 nm in TBS buffer (Nam and Ge, 2013; Knight et al., 1992) . The half maximal inhibitory concentration (IC 50 ) was calculated from a four-parametric logistic curve-fitting analysis.
ScFv Cloning and Yeast Display. The Fab genes of 1F8, 2A10 were modified to their scFv formats for yeast surface display. For each antibody clone, VH/VL fragment was amplified by PCR, and scFvs were assembled by overlapping PCR. The scFv genes of DX-2400 (as a positive control) and M18 (as a negative control) were PCR amplified from pMoPac-DX2400 and pMoPac-M18. Obtained scFv genes were cloned into NheI/BamHI sites of yeast surface display plasmid pCTCON-2, which has Aga2p protein at N-terminal for surface anchoring and a c-Myc tag at C-terminal for detection of expression. The resulting antibody display plasmids were transformed into yeast EBY100 cells by EZ transformation II kit (Zymo Research), and cells were selected on SDCAA plates at 30 °C overnight. The SDCAA medium contains 5 g/L casamino acids, 20 g/L dextrose, 1.7 g/L YNB (Yeast Nitrogen Base without ammonium sulfate amino acids), 10.19 g/L Na 2 HPO 4 -7H 2 O, and 8.56 g/L NaH 2 PO 4 -H 2 O. For each antibody clone, a single yeast colony was picked to inoculate into 5 mL SDCAA medium and cultured overnight at 30 °C and 225 rpm. When the culture reached 4 OD 600 , the cells were centrifuged at 3000 ×g for 5 min. After the supernatant was discarded, the cell pellets were resuspended in 20 mL SGCAA medium, which was similar to SDCAA medium except 20 g/L galactose instead of 20 g/L dextrose was used. The cells were continuously cultured at 25 °C and 225 rpm for 48 h for antibody expression on the yeast surface.
FACS Scanning. 0.1 OD 600 of yeast cells displaying scFv antibodies and untransformed cells were harvested by centrifugation, and resuspended in TBS buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.5). Primary chicken anti-c-Myc IgY (Invitrogen) was added to cell suspensions at 1:500 dilution. After incubation with shaking at room temperature for 30 min, cells were centrifuged at 3,000 ×g for 5 min and washed once with TBS buffer. Secondary Alexa Fluor 647-goat anti-chicken IgG (Invitrogen) was then added at 1:100 dilution, and incubated with shaking on ice for 20 min. After washing once, the cells were resuspended in 500 μl TBS buffer for FACS scanning using a FACSAria (BD) cytometer. The power of 633 nm laser and SSC and FSC gains were adjusted to distinguish scFv displaying cells from untransformed cells as the negative control. For Alexa488-MMP14 and Alexa647-nTIMP2 dual color labeling, 0.1 OD 600 cell suspensions were incubated with 4 μg/mL of Alexa488-MMP14 at room temperature for 30 min then 16 μg/mL of Alexa647-nTIMP2 at 4 °C for 20 min. The fluorescence thresholds were adjusted using a positive control clone displaying DX-2400 scFv and negative control clones displaying non-relevant scFv M18 or non-specific scFv 2A10 identified in this study. For binding specific test, the procedures were the same except using 200 nM Alexa647-MMP9 instead of Alexa 647-nTIMP2.
Structural Simulations of 1F8 / cdMMP-14 complex. The sequences of heavy chain and light chain variable were submitted to ABodyBuilder antibody modeling program in SAbPred server (http://opig.stats.ox.ac.uk/webapps/sabdab-sabpred/WelcomeSAbPred.php; to generate homology modeling of Fab 1F8. The sequences were annotated with Kabat numbering scheme. Possible epitope and partope were predicted using EpiPred and Antibody iPatch programs respectively. ZDOCK was used to simulate complex of Fab 1F8 and cdMMP-14 using high-ranked epitope and paratope residues (http://zdock.umassmed.edu/; . Images of complex were generated by PyMOL.
